Impact on weight and physical function of intensive medical weight loss in older adults with stage II and III obesity

Jamy D Ard, Miranda Cook, Julia Rushing, Annette Frain, Kristen Beavers, Gary Miller, Michael E Miller, Barb Nicklas, Jamy D Ard, Miranda Cook, Julia Rushing, Annette Frain, Kristen Beavers, Gary Miller, Michael E Miller, Barb Nicklas

Abstract

Objective: A 6-month pilot trial compared two strategies for weight loss in older adults with body mass indexes (BMIs) ≥35 kg/m(2) to assess weight loss response, safety, and impact on physical function.

Methods: Twenty-eight volunteers were randomized to a balanced deficit diet (BDD) (500 kcal/day below estimated energy needs) or an intensive, low-calorie, meal replacement diet (ILCD, 960 kcal/day). Behavioral interventions and physical activity prescriptions were similar for both groups. Primary outcomes were changes in body weight and adverse event frequency; secondary outcomes included measures of physical function and body composition.

Results: ILCD average weight change was -19.1 ± 2.2 kg or 15.9 ± 4.6% of initial body weight compared with -9.1 ± 2.7 kg or 7.2 ± 1.9% for BDD. ILCD lost more fat mass (-7.7 kg, 95% CI [-11.9 to -3.5]) but had similar loss of lean mass (-1.7 kg, 95% CI [-4.1 to 0.6]) compared with BDD. There were no significant differences in change in physical function or adverse event frequency.

Conclusions: Compared with a traditional BDD intervention, older adults who have severe obesity treated with intensive medical weight loss had greater weight loss and decreases in fat mass without a higher frequency of adverse events. In the short term, however, this did not translate into greater improvements in physical function.

© 2016 The Obesity Society.

Figures

Figure 1
Figure 1
Percent change in body weight based on weekly clinic measures Lines represent mean change in percent of initial body weight over the course of the intervention
Figure 2
Figure 2
Changes in total fat mass (kg) by DXA Bars represent mean fat mass in kg with standard deviation at baseline and 6 month follow up

Source: PubMed

3
Abonnere